Mishra Priyanka, Tripathi Preeti, Halder Rohan, Saxena Renu, Tyagi Seema, Mahapatra Manoranjan, Pati H P
Department of Hematology, All India Institute of Medical Sciences, New Delhi, 110049 India.
Department of Hematopathology, Command Hospital Airforce Bangalore, Bangalore, India.
Indian J Hematol Blood Transfus. 2021 Apr;37(2):220-225. doi: 10.1007/s12288-020-01302-y. Epub 2020 Jun 10.
PNH is a rare disease with wide spectrum of intra-vascular hemolysis and thrombosis to sub-clinical PNH clones. We aimed to study the clinico-hematological profile and clone size on granulocytes and monocytes of PNH patients classified as per International PNH Interest Group recommendations. A retrospective analysis of clinico-hematological profile of 112 PNH clone positive patients by FLAER based flow cytometry between January and September 2017 done and classified into classical PNH, PNH with aplastic anemia or myelodysplastic syndrome (PNH-AA/MDS) and sub-clinical PNH clones (PNH-sc). Of 112 patients, majority were PNH-sc (62) followed by PNH-AA/MDS (34) and classical PNH (16). The commonest clinical feature was anemia in all 3 groups followed by jaundice (87.5%) in classical PNH and fever in PNH-AA/MDS (64.7%) and PNH-sc (48.4%). Thrombosis was present in 25% (4/16) classical PNH and 2.9% (1/34) of PNH-AA/MDS. The mean hemoglobin, reticulocyte count and LDH was higher in classical PNH. Bone marrow was predominantly hypercellular in classical PNH (11/16) and hypocellular in PNH-AA/MDS (31/34) and PNH-sc (50/62) with dyserythropoiesis predominantly in PNH-AA/MDS (83.8%) and PNH-sc (74.1%). Marrow iron was reduced in 62.2% classical PNH contrary to increased in PNH-BMF (58%) and PNH-sc (91%). The mean clone size in PNH-sc was significantly lower with > 50% in 16.2% patients. Three patients with MDS-MLD and MDS-MLD-RS in PNH-sc had > 80% clone on granulocytes and monocytes. Most PNH patients in Indian setting are PNH-sc with significantly lower clone, however, a clone size > 50% is not uncommon in Indian PNH-sc.
阵发性睡眠性血红蛋白尿症(PNH)是一种罕见疾病,表现为从血管内溶血和血栓形成到亚临床PNH克隆的广泛症状。我们旨在研究根据国际PNH兴趣小组建议分类的PNH患者的临床血液学特征以及粒细胞和单核细胞上的克隆大小。对2017年1月至9月期间通过基于FLAER的流式细胞术检测的112例PNH克隆阳性患者的临床血液学特征进行回顾性分析,并将其分为经典型PNH、合并再生障碍性贫血或骨髓增生异常综合征的PNH(PNH-AA/MDS)以及亚临床PNH克隆(PNH-sc)。在112例患者中,大多数为PNH-sc(62例),其次是PNH-AA/MDS(34例)和经典型PNH(16例)。所有3组中最常见的临床特征是贫血,其次是经典型PNH中的黄疸(87.5%)以及PNH-AA/MDS(64.7%)和PNH-sc(48.4%)中的发热。25%(4/16)的经典型PNH和2.9%(1/34)的PNH-AA/MDS存在血栓形成。经典型PNH的平均血红蛋白、网织红细胞计数和乳酸脱氢酶水平较高。经典型PNH的骨髓主要为细胞增多(11/16),PNH-AA/MDS(31/34)和PNH-sc(50/62)的骨髓为细胞减少,其中PNH-AA/MDS(83.8%)和PNH-sc(74.1%)主要存在红细胞生成异常。62.2%的经典型PNH骨髓铁减少,而PNH-骨髓纤维化(PNH-BMF,58%)和PNH-sc(91%)的骨髓铁增加。PNH-sc的平均克隆大小显著较低,16.2%的患者克隆大小>50%。3例PNH-sc中合并骨髓增生异常综合征伴轻度发育异常(MDS-MLD)和MDS-MLD伴环形铁粒幼细胞(MDS-MLD-RS)的患者粒细胞和单核细胞上的克隆>80%。在印度,大多数PNH患者为PNH-sc,克隆大小显著较低,然而,克隆大小>50%在印度PNH-sc中并不罕见。